See every side of every news story

Browser Extension

Sunday, April 6, 2025

US Edition

Subscribe Login

Israel-Hamas Conflict

Natural Disasters

medicineslawandpolicy.org image

News from medicineslawandpolicy.org

News Home Page Local News Blindspot Feed International Covid-19

International North America South America Europe Asia Australia Africa

Trending Internationally Baseball Natural Disasters Social Media Tariffs South America

Trending in U.S.Israel-Hamas Conflict Baseball Natural Disasters Floods US Politics

Trending in U.K.Israel-Hamas Conflict Premier League Arsenal FC Soccer Celtic

Trending Topics

Baseball Natural Disasters Social Media Tariffs Israel-Hamas Conflict

CompanyAbout History Mission Blog Testimonials Group Subscriptions Subscribe Gift Free Trial Careers Affiliates

HelpHelp Center FAQ Contact Us For Educators/Libraries Media Bias Ratings Ownership and Factuality Ratings Referral Code News Sources Topics

ToolsApp Browser Extension Daily Newsletter Blindspot Report Newsletter Burst Your Bubble Newsletter Timelines

Gift Privacy Policy Manage Cookies Terms and Conditions

© 2025 Snapwise Inc

Search Blindspot Local

News from medicineslawandpolicy.org

All of today’s top news stories from medicineslawandpolicy.org. Get the full analysis behind how media bias impacts breaking news.

Ground News has come across 6 headlines reported on by medicineslawandpolicy.org during the past 3 months.

Ground News rates medicineslawandpolicy.org’s media bias as . . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Is medicineslawandpolicy.org credible or reliable? Our Factuality score answers both of those questions. When it comes to medicineslawandpolicy.org, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

All of today’s top news stories from medicineslawandpolicy.org. Get the full analysis behind how media bias impacts breaking news. Ground News has come across 6 headlines reported on by medicineslawandpolicy.org during the past 3 months.

Ground News rates medicineslawandpolicy.org’s media bias as . . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. Is medicineslawandpolicy.org credible or reliable? Our Factuality score answers both of those questions. When it comes to medicineslawandpolicy.org, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about medicineslawandpolicy.org

Where is medicineslawandpolicy.org located?medicineslawandpolicy.org's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top medicineslawandpolicy.org News

Will Europe block the Pandemic Agreement because of one word? | Medicines Law & Policy

Geneva, Switzerland · Geneva

Will Europe block the Pandemic Agreement because of one word? | Medicines Law & Policy

This commentary originally appeared in the Brussels Times, and is available here. The Pandemic Agreement negotiations began in December of 2021. Sufficiently motivated by the devastation brought by the COVID-19 global outbreak, member states of the WHO agreed to start negotiations for an international agreement to prevent, prepare for, and respond to pandemics. At the heart of this decision was the overarching goal of addressing the unacceptable…See the Story

You've scrolled to the bottom of the feed, there are no more stories.

A better way to solve a crisis: A new mechanism for incentivising R&D on new antimicrobials | Medicines Law & Policy

A better way to solve a crisis: A new mechanism for incentivising R&D on new antimicrobials | Medicines Law & Policy

Antimicrobial resistance is the ‘silent’ pandemic: Globally, it costs 5 million lives a year, and is set to rise to more than 8 million lives lost a year by 2050. In the European Union alone, it is the cause of 35,000 deaths a year, and this number is also expected to increase. Decisive action is needed to avert this growing threat to public health. A major challenge is that the current model for medicines development is not well suited to incen…See the Story

The world needs a signal that multilateralism works: ML&P opening statement to the INB13, 17 February 2025 | Medicines Law & Policy

The world needs a signal that multilateralism works: ML&P opening statement to the INB13, 17 February 2025 | Medicines Law & Policy

Thank you for the opportunity to make a brief statement. The negotiations for the Pandemic Agreement enter the final phase. We hope and wish for a good (green) agreement to be taken to the WHA in May. A pandemic agreement that: recognises the need for international solidarity and collaboration in preventing and responding to pandemics, recognises the importance of equitable access to pandemic countermeasures, ensures sharing of medical tech…See the Story

Synthesis and Conclusions: Securing technology transfer in the Pandemic Agreement | Medicines Law & Policy

Geneva, Switzerland · Geneva

Synthesis and Conclusions: Securing technology transfer in the Pandemic Agreement | Medicines Law & Policy

This guest blog draws from a synthesis report made after a 27 January 2025 expert workshop at the Geneva Graduate Institute entitled Technology Transfer in Practice: Implications for Pandemic Agreement Negotiations. The full report, which includes interviews with the experts, was originally published here. One of the invited experts was ML&P’s Ellen ‘t Hoen. Introduction Technology transfer has been one of the more politically and technically di…See the Story